SEBI imposes fine on Aurobindo Pharma

SEBI imposes Rs. 22 cr fine on Aurobindo Pharma for insider trading

Points to Remember:

  • Markets regulator SEBI has imposed over Rs. 22 crore penalty on Aurobindo Pharma and its promoters for violation of provisions of insider trading.
  • The insider trading was in relation to a licencing deal it had entered with Pfizer in 2009.
  • SEBI said it carried out investigations in Aurobindo Pharma between 2008-09 following a sudden increase in the share price.

About SEBI :

  • The Securities and Exchange Board of India is the regulator for the securities market in India.
  • It was established in 1988 and given statutory powers on 12 April 1992 through the SEBI Act, 1992.
  • Founded: 12 April 1992
  • Sector: Securities market
  • Headquarters: Mumbai
  • Type: Statutory corporation
  • Chairperson: Ajay Tyagi
Important Possible questions based on above News:
  1. Market regulator _ has imposed over Rs. 22 crore penalty on Aurobindo Pharma. SEBI
  2. Who is the chairman of SEBi at present? Ajay Tyagi



Your email address will not be published. Required fields are marked *